These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 4545897)

  • 1. Separable populations of activated thymus-derived lymphocytes identified in two assays for cell-mediated immunity to murine tumor allografts.
    Tigelaar RE; Gorczynski RM
    J Exp Med; 1974 Jul; 140(1):267-89. PubMed ID: 4545897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens.
    Kedar E; Bonavida B
    J Immunol; 1975 Nov; 115(5):1301-8. PubMed ID: 51889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated immunity to Murine tumor allografts. Increase in the activities of activated thymus-derived cells following in vitro incubation.
    Gorczynski RM; Tigelaar RE
    Cell Immunol; 1975 Jul; 18(1):121-43. PubMed ID: 806353
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune response to a transplantable malignant melanoma in mice.
    Bartholomaeus WN; Bray AE; Papadimitriou JM; Keast D
    J Natl Cancer Inst; 1974 Oct; 53(4):1065-72. PubMed ID: 4547798
    [No Abstract]   [Full Text] [Related]  

  • 5. Cellular basis for the immune response to methylcholanthrene-induced tumors in mice. Heterogeneity of effector cells.
    Kearney R; Basten A; Nelson DS
    Int J Cancer; 1975 Mar; 15(3):438-50. PubMed ID: 1079792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro stimulation and inhibition of tumor cell growth mediated by different lymphoid cell populations.
    Norbury KC
    Cancer Res; 1977 May; 37(5):1408-15. PubMed ID: 66982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors.
    Fortner GW; Kripke ML
    J Immunol; 1977 Apr; 118(4):1483-7. PubMed ID: 66296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractionation of lymphocyte subpopulations which regulate mixed lymphocyte reactions.
    Rich RR; Chu L; Rich SS
    J Immunol; 1977 Apr; 118(4):1252-8. PubMed ID: 139451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of host lymphocytes and host macrophages in antitumor reactions after injection of sensitized lymphocytes and tumor target cells into naive mice.
    Dullens HF; Vuist W; Van der Maas M; Den Otter W
    Cancer Immunol Immunother; 1986; 23(2):113-8. PubMed ID: 3536093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-mediated antitumor immune reactions under syngeneic conditions.
    Leclerc JC; Senik A; Gomard E; Plata F; Levy JP
    Transplant Proc; 1973 Dec; 5(4):1431-4. PubMed ID: 4359721
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell-mediated immune responses in vitro. I. Suppression of the generation of cytotoxic lymphocytes by concanavalin A and concanavalin A-activated spleen cells.
    Peavy DL; Pierce CW
    J Exp Med; 1974 Aug; 140(2):356-69. PubMed ID: 4276949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro induction of tumor-specific immunity. I. Parameters of activation and cytotoxic reactivity of mouse lymphoid cells immunized in vitro against syngeneic and allogeneic plasma cell tumors.
    Wagner H; Röllinghoff M
    J Exp Med; 1973 Jul; 138(1):1-15. PubMed ID: 4541509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymus-derived lymphocytes produce an immunologically specific macrophage-arming factor.
    Evans R; Grant CK; Cox H; Steele K; Alexander P
    J Exp Med; 1972 Nov; 136(5):1318-22. PubMed ID: 4117192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of cytotoxic T lymphocytes in vitro. I. Response of normal and immune mouse spleen cells in mixed leukocyte cultures.
    Cerottini JC; Engers HD; Macdonald HR; Brunner T
    J Exp Med; 1974 Sep; 140(3):703-17. PubMed ID: 4278108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of a subpopulation of T cells bearing histamine receptors.
    Plaut M; Lichtenstein LM; Henney CS
    J Clin Invest; 1975 Apr; 55(4):856-74. PubMed ID: 164483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage cytotoxicity factor. A product of in vitro sensitized thymus-dependent cells.
    Lohmann-Matthes ML; Ziegler FG; Fischer H
    Eur J Immunol; 1973 Jan; 3(1):56-8. PubMed ID: 4197970
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of two bisdioxopiperazines on mouse B-and T-cell function.
    Dennert G; Hatlen LE; Tucker DF
    J Natl Cancer Inst; 1975 Mar; 54(3):621-9. PubMed ID: 804564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor immunity to murine plasma cell tumors. II. Essential role of T lymphocytes in immune response.
    Rouse BT; Röllinghoff M; Warner NL
    Eur J Immunol; 1973 Apr; 3(4):218-24. PubMed ID: 4541468
    [No Abstract]   [Full Text] [Related]  

  • 19. Destruction of experimental malignant melanoma by mediators of cellular immunity.
    Youdim S
    Cancer Res; 1977 Feb; 37(2):572-7. PubMed ID: 401681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of suppressor macrophages for immunosurveillance of tumor-bearing mice.
    Fujii T; Igarashi T; Kishimoto S
    J Natl Cancer Inst; 1987 Mar; 78(3):509-17. PubMed ID: 2950265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.